Cargando…
Surgical treatment in malignant pleural effusion
Malignant pleural effusion can be described as the presence of exudate in the pleural space, accompanied by the detection of cancer cells in pleural fluid or tissue, which is the indicator of the disease in its advance stages, and survival time of these patients ranges between 3 and 12 months. Treat...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bayçınar Medical Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762910/ https://www.ncbi.nlm.nih.gov/pubmed/35096460 http://dx.doi.org/10.5606/tgkdc.dergisi.2021.20580 |
_version_ | 1784633844830306304 |
---|---|
author | Karadayı, Şule Şahin, Ekber |
author_facet | Karadayı, Şule Şahin, Ekber |
author_sort | Karadayı, Şule |
collection | PubMed |
description | Malignant pleural effusion can be described as the presence of exudate in the pleural space, accompanied by the detection of cancer cells in pleural fluid or tissue, which is the indicator of the disease in its advance stages, and survival time of these patients ranges between 3 and 12 months. Treatment options for malignant pleural effusion vary from observation in asymptomatic patients to pleurectomies or even extrapleural pneumonectomies in severe cases. |
format | Online Article Text |
id | pubmed-8762910 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Bayçınar Medical Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-87629102022-01-27 Surgical treatment in malignant pleural effusion Karadayı, Şule Şahin, Ekber Turk Gogus Kalp Damar Cerrahisi Derg Review Article Malignant pleural effusion can be described as the presence of exudate in the pleural space, accompanied by the detection of cancer cells in pleural fluid or tissue, which is the indicator of the disease in its advance stages, and survival time of these patients ranges between 3 and 12 months. Treatment options for malignant pleural effusion vary from observation in asymptomatic patients to pleurectomies or even extrapleural pneumonectomies in severe cases. Bayçınar Medical Publishing 2021-10-20 /pmc/articles/PMC8762910/ /pubmed/35096460 http://dx.doi.org/10.5606/tgkdc.dergisi.2021.20580 Text en Copyright © 2021, Turkish Society of Cardiovascular Surgery https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Review Article Karadayı, Şule Şahin, Ekber Surgical treatment in malignant pleural effusion |
title | Surgical treatment in malignant pleural effusion |
title_full | Surgical treatment in malignant pleural effusion |
title_fullStr | Surgical treatment in malignant pleural effusion |
title_full_unstemmed | Surgical treatment in malignant pleural effusion |
title_short | Surgical treatment in malignant pleural effusion |
title_sort | surgical treatment in malignant pleural effusion |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762910/ https://www.ncbi.nlm.nih.gov/pubmed/35096460 http://dx.doi.org/10.5606/tgkdc.dergisi.2021.20580 |
work_keys_str_mv | AT karadayısule surgicaltreatmentinmalignantpleuraleffusion AT sahinekber surgicaltreatmentinmalignantpleuraleffusion |